全胰腺切除术后的临床结局:一项前瞻性多中心泛欧洲快照研究
该前瞻性泛欧洲快照研究纳入16国43中心277例择期全胰腺切除术患者,主要针对恶性肿瘤(73%)。主要并发症发生率为25%,住院死亡率为5%,90天死亡率为8%。年胰十二指肠切除术量<60例、年龄及估计失血量≥2L与住院死亡率相关。
要点
- 全胰腺切除术后住院死亡率为5%,90天死亡率为8%。
- 年胰十二指肠切除术量<60例的中心住院死亡率高于≥60例中心(10% vs 4%,P=0.046)。
- 估计失血量≥2L与住院死亡率(OR 11.89)及主要并发症(OR 3.52)相关。
核心结论
- 泛欧洲前瞻性快照研究显示全胰腺切除术后住院死亡率为5%。
- 低容量中心、年龄及失血量增加是住院死亡率的预测因素,可用于改善结局。
研究设计与样本
- 前瞻性泛欧洲快照研究,纳入2018年6月至2019年6月16国43中心277例择期全胰腺切除术患者。
- 亚组分析按年胰十二指肠切除术量<60例 vs ≥60例分组,采用多变量logistic回归评估主要并发症和住院死亡率的预测因素。
主要发现
- 277例患者中73%为恶性肿瘤,主要术后并发症发生70例(25%)。
- 中位住院时间12天(IQR 9-18),40例(15%)再入院。
- 住院死亡率5%,90天死亡率8%。
- 年胰十二指肠切除术量<60例的中心住院死亡率高于≥60例中心(10% vs 4%,P=0.046)。
- 多变量分析中,年胰十二指肠切除术量<60例(OR 3.78,95%CI 1.18-12.16,P=0.026)、年龄(OR 1.07,95%CI 1.01-1.14,P=0.046)及估计失血量≥2L(OR 11.89,95%CI 2.64-53.61,P=0.001)与住院死亡率相关;ASA≥3(OR 2.87,95%CI 1.56-5.26,P=0.001)及估计失血量≥2L(OR 3.52,95%CI 1.25-9.90,P=0.017)与主要并发症相关。
临床怎么用
- 全胰腺切除术应优先在年胰十二指肠切除术量≥60例的中心开展以降低住院死亡率。
- 围术期应关注年龄、ASA≥3及估计失血量≥2L等高危因素,优化患者选择与术中止血。
局限性
- 研究为快照设计,随访时间有限,仅报告住院及90天结局。
- 亚组分析样本量较小,预测因素结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess outcomes among patients undergoing total pancreatectomy (TP) including predictors for complications and in-hospital mortality. BACKGROUND: Current studies on TP mostly originate from high-volume centers and span long time periods and therefore may not reflect daily practice. METHODS: This prospective pan-European snapshot study included patients who underwent elective (primary or completion) TP in 43 centers in 16 European countries (June 2018-June 2019). Subgroup analysis included cutoff values for annual volume of pancreatoduodenectomies (<60 vs ≥60).Predictors for major complications and in-hospital mortality were assessed in multivariable logistic regression. RESULTS: In total, 277 patients underwent TP, mostly for malignant disease (73%). Major postoperative complications occurred in 70 patients (25%). Median hospital stay was 12 days (IQR 9-18) and 40 patients were readmitted (15%). In-hospital mortality was 5% and 90-day mortality 8%. In the subgroup analysis, in-hospital mortality was lower in patients operated in centers with ≥60 pancreatoduodenectomies compared <60 (4% vs 10%, P = 0.046). In multivariable analysis, annual volume <60 pancreatoduodenectomies (OR 3.78, 95% CI 1.18-12.16, P = 0.026), age (OR 1.07, 95% CI 1.01-1.14, P = 0.046), and estimated blood loss ≥2L (OR 11.89, 95% CI 2.64-53.61, P = 0.001) were associated with in-hospital mortality. ASA ≥3 (OR 2.87, 95% CI 1.56-5.26, P = 0.001) and estimated blood loss ≥2L (OR 3.52, 95% CI 1.25-9.90, P = 0.017) were associated with major complications. CONCLUSION: This pan-European prospective snapshot study found a 5% inhospital mortality after TP. The identified predictors for mortality, including low-volume centers, age, and increased blood loss, may be used to improve outcomes.
引用
- Latenstein AEJ, Scholten L, Al-Saffar HA, et al. Clinical Outcomes After Total Pancreatectomy: A Prospective Multicenter Pan-European Snapshot Study. Ann Surg. 2020. PMID: 33177356. doi:10.1097/SLA.0000000000004551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。